Estradiol Tablets USP
Company: Barr Laboratories
Approval Status: Approved October 1997
Treatment for: post-menopausal osteoporosis
Areas: Endocrinology; Musculoskeletal; Obstetrics/Gynecology
Possible similar drugs: Estradiol; Estradiol Transdermal System
General Information
Other Useful Resources
Estradiol Tablets, the generic equivalent of Bristol Myers Squibb's Estrace, has been approved for marketing. Barr's Estradiol will be available in .5, 1, and 2 mg strengths. Estradiol is used to treat moderate to severe vasomotor symptoms associated with menopause as well as for the prevention of osteoporosis.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
